Literature DB >> 19728765

Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane.

L Hunakova1, O Sedlakova, D Cholujova, P Gronesova, J Duraj, J Sedlak.   

Abstract

Metastasis as a complex process involves loss of adhesion, migration, invasion and proliferation of cancer cells. Sulforaphane (SFN) is one of naturally occurring cancer chemopreventive isothiocyanates found in cruciferous vegetables, consumption of which has been associated with reduced risk of cancer. In this study, we describe effect of SFN on various aspects determining invasive behavior of MDA-MB-231 human breast carcinoma cells. We studied modulation of molecules associated with epithelial to mesenchymal transition (EMT), hypoxic marker CA IX and mitochondrially located peripheral benzodiazepine receptor (PBR) using flow cytometry, gene expression of matrix metalloproteinases MMP1, 3, 7, 9, 14, transcription factors POU5F1 and Twist1 mRNA by RT PCR, and cytokine production by multiplex bead assay. SFN downregulated PBR and vimentin expression in a dose dependent manner, but significantly affected neither HIF-1alpha, nor CA IX protein expression, nor VEGF and GLUT1 mRNA levels. Among studied MMPs, MMP7 and MMP14 mRNA were downregulated while no apparent effect on MMP1, MMP3 and MMP9 was observed. Further, we found significant down regulation of Twist1 and POU5F1, transcription factors that mediate EMT and the self-renewal of undifferentiated embryonic stem cells. SFN reduced also the production of pro-inflammatory cytokines IL-1beta, IL-6, TNF-alpha, IFN-gamma, immunomodulating cytokine IL-4 and growth factors involved in angiogenesis PDGF and VEGF. Our study shows that SFN efficacy is associated with the reversal of several biological characteristics connected with EMT or implicated in the matrix degradation and extracellular proteolysis, as well as with reduced production of pro-inflammatory cytokines and pro-angiogenic growth factors in MDA-MB-231 cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728765     DOI: 10.4149/neo_2009_06_548

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  14 in total

1.  Cross-regulation between protein L-isoaspartyl O-methyltransferase and ERK in epithelial mesenchymal transition of MDA-MB-231 cells.

Authors:  Jiyeon Ryu; Jihyeok Song; Jieun Heo; Yongwoo Jung; Sang-Jin Lee; Sungyoul Hong; Jae Youl Cho
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

2.  Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.

Authors:  Georgios Kallifatidis; Sabrina Labsch; Vanessa Rausch; Juergen Mattern; Jury Gladkich; Gerhard Moldenhauer; Markus W Büchler; Alexei V Salnikov; Ingrid Herr
Journal:  Mol Ther       Date:  2010-10-12       Impact factor: 11.454

Review 3.  Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.

Authors:  Kah Min Yap; Mahendran Sekar; Shivkanya Fuloria; Yuan Seng Wu; Siew Hua Gan; Nur Najihah Izzati Mat Rani; Vetriselvan Subramaniyan; Chandrakant Kokare; Pei Teng Lum; M Yasmin Begum; Shankar Mani; Dhanalekshmi Unnikrishnan Meenakshi; Kathiresan V Sathasivam; Neeraj Kumar Fuloria
Journal:  Int J Nanomedicine       Date:  2021-12-02

4.  Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells.

Authors:  Xiang Wu; Yu Zhu; Huiqin Yan; Boning Liu; Ying Li; Qinghua Zhou; Ke Xu
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

Review 5.  Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Roy A Jensen; Shrikant Anant
Journal:  Semin Cancer Biol       Date:  2016-09-05       Impact factor: 15.707

6.  Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.

Authors:  Shih-Hui Li; Junsheng Fu; Dara Nall Watkins; Rakesh K Srivastava; Sharmila Shankar
Journal:  Mol Cell Biochem       Date:  2012-11-06       Impact factor: 3.396

7.  Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal.

Authors:  Mariana Rodova; Junsheng Fu; Dara Nall Watkins; Rakesh K Srivastava; Sharmila Shankar
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis.

Authors:  Shorafidinkhuja Dadakhujaev; Carolina Salazar-Arcila; Stuart J Netherton; Amrita Singh Chandhoke; Arvind Kumar Singla; Frank R Jirik; Shirin Bonni
Journal:  Oncoscience       Date:  2014-03-31

Review 9.  Natural products as potential cancer therapy enhancers: A preclinical update.

Authors:  Abed Agbarya; Nili Ruimi; Ron Epelbaum; Eran Ben-Arye; Jamal Mahajna
Journal:  SAGE Open Med       Date:  2014-09-02

10.  FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines.

Authors:  Ali Abolhassani; Gholam Hossein Riazi; Ebrahim Azizi; Saeid Amanpour; Samad Muhammadnejad; Mahnaz Haddadi; Ali Zekri; Reza Shirkoohi
Journal:  J Cancer       Date:  2014-06-21       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.